Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience

• Daniele Cattaneo,
• Cristina Bucelli,
• Francesca Cavallaro,
• Dario Consonni,
• Alessandra Iurlo

Affiliations

Daniele Cattaneo

Hematology Division, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico

Cristina Bucelli

Hematology Division, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico

Francesca Cavallaro

Department of Oncology and Hemato-Oncology, University of Milan

Dario Consonni

Epidemiology Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico

Alessandra Iurlo

Hematology Division, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico